Trusight Software Suite News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Trusight software suite. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Trusight Software Suite Today - Breaking & Trending Today

Illumina, Emedgene Launch AI-Based Rare Disease Interpretation Partnership


Illumina, Emedgene Launch AI-Based Rare Disease Interpretation Partnership
Illumina has launched a nonexclusive partnership with Emedgene, an artificial intelligence-based precision medicine company, to integrate automated interpretation of rare genetic disease data into Illumina’s TruSight™ Software Suite.
Through the collaboration, whose value has not been disclosed, TruSight will include Emedgene’s clinical rare disease application, one of a portfolio of artificial intelligence (AI)-powered applications for high-throughput genomic interpretation across clinical and research use cases.
Illumina and Emedgene reason that through AI-enhanced interrogation of medical literature and phenotypes associated with rare disease, researchers will be better able to make new and unexpected discoveries based on rare disease data. ....

Marcos Gonzales , Einat Metzer , Trusight Software Suite , Software Suite , Basespace Sequence Hub , Sight Software Suite , Cognitive Genomics Intelligence , Natural Language Processing , மார்கோஸ் காந்ஸாலஸ் , மென்பொருள் தொகுப்பு , பார்வை மென்பொருள் தொகுப்பு , அறிவாற்றல் மரபியல் உளவுத்துறை , இயற்கை மொழி ப்ரோஸெஸிஂக் ,

Emedgene collaborates with Illumina to scale the interpretation of genomic data for rare diseases


Emedgene collaborates with Illumina to scale the interpretation of genomic data for rare diseases
USA - English
News provided by
Share this article
Share this article
PALO ALTO, California, Dec. 16, 2020 /PRNewswire/  Emedgene, a leading precision medicine intelligence company, announces a non-exclusive partnership with
Illumina Inc. and the integration of automated interpretation into Illumina s TruSight™ Software Suite for rare genetic diseases. Emedgene s Clinical Rare Disease application is one of a portfolio of artificial intelligence (AI)-powered applications for high-throughput genomic interpretation across clinical and research use cases.
Healthcare is in the midst of a leap towards precision medicine. Continued improvements in the cost of next-generation sequencing (NGS) technologies, such as those developed by Illumina, have dramatically accelerated the adoption of genetic testing. Consequently, data generated from genomics doubles every ....

United States , Ryan Taft , Einat Metzer , Emedgene Co , Illumina Trusight Software Suite , Trusight Software Suite , Software Suite , Illumina Inc , Scientific Research At Illumina , Clinical Rare Disease , Scientific Research , ஒன்றுபட்டது மாநிலங்களில் , ரியான் ட்யாஃப்ட் , மென்பொருள் தொகுப்பு , இல்லுமின இன்க் , அறிவியல் ஆராய்ச்சி இல் இல்லுமின , மருத்துவ ரேர் நோய் , அறிவியல் ஆராய்ச்சி ,